Giovanni Insuasti-Beltran to Humans
This is a "connection" page, showing publications Giovanni Insuasti-Beltran has written about Humans.
Connection Strength
0.099
-
Post SR, Post GR, Nikolic D, Owens R, Insuasti-Beltran G. Development of an unbiased, semi-automated approach for classifying plasma cell immunophenotype following multicolor flow cytometry of bone marrow aspirates. Cytometry B Clin Cytom. 2018 09; 94(5):602-610.
Score: 0.036
-
Insuasti-Beltran G, Gale JM, Wilson CS, Foucar K, Czuchlewski DR. Significance of MYD88 L265P Mutation Status in the Subclassification of Low-Grade B-Cell Lymphoma/Leukemia. Arch Pathol Lab Med. 2015 Aug; 139(8):1035-41.
Score: 0.030
-
Insuasti-Beltran G, Steidler NL, Kang H, Reichard KK. CD34+ megakaryocytes (=30%) are associated with megaloblastic anaemia and non-acute myeloid neoplasia. Histopathology. 2012 Oct; 61(4):694-701.
Score: 0.025
-
Schinke C, Hoering A, Wang H, Carlton V, Thanandrarajan S, Deshpande S, Patel P, Molnar G, Susanibar S, Mohan M, Mathur P, Radhakrishnan M, Hoque S, Jo Kamimoto J, Grazziutti M, van Rhee F, Zangari M, Insuasti-Beltran G, Alapat D, Post G, Yaccoby S, Epstein J, Rasche L, Johnson S, Moorhead M, Willis T, Barlogie B, Walker B, Weinhold N, Davies FE, Morgan GJ. The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype. Haematologica. 2017 08; 102(8):e313-e316.
Score: 0.008